Quinidine partially blocks mitochondrial voltage-dependent anion channel (VDAC)

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Quinidine is a widely used antiarrhythmic medication.
• Mitochondria play crucial roles in cellular energy production and calcium homeostasis.
• Mitochondrial voltage-dependent anion channel (VDAC) is a key porin in the outer mitochondrial membrane.

Purpose of the Study:

• To investigate the interaction between Quinidine and the mitochondrial VDAC.
• To elucidate the mechanism by which Quinidine affects VDAC function.

Main Methods:

• Purification of VDAC from Wistar rat neuronal tissue.
• In vitro bilayer electrophysiology experiments to measure VDAC conductance.
• In silico molecular docking studies using Autodock-4.2.
• Fluorescence spectroscopy to analyze Quinidine-amino acid interactions.

Main Results:

• Quinidine (50 mM) caused a significant drop in VDAC conductance.
• Half-maximal inhibitory concentration (IC50) for Quinidine on VDAC was determined.
• Molecular docking indicated Quinidine interacts with Glutamic acid residue (Glu-206) of VDAC.
• Fluorescence spectroscopy confirmed Quinidine binds to Glutamic acid but not Cysteine.

Conclusions:

• Quinidine partially blocks VDAC activity.
• The interaction is mediated by Quinidine binding to Glutamic acid residues within the VDAC pore.
• This finding provides insights into the molecular mechanisms of Quinidine's effects on mitochondrial function.